Related Experiment Video

Updated: Jul 14, 2026

Minimal Erythema Dose (MED) Testing
06:24

Minimal Erythema Dose (MED) Testing

Published on: May 28, 2013

Quantifying the federal minimal risk standard: implications for pediatric research without a prospect of direct

David Wendler1, Leah Belsky, Kimberly M Thompson

  • 1Department of Clinical Bioethics, NIH Clinical Center, National Institutes of Health, Bethesda, Md 20892, USA. dwendler@nih.gov

JAMA
|August 18, 2005
PubMed

Insights

Institutional review boards (IRBs) often apply pediatric research risk standards too cautiously. Empirical data on risks from daily life, like car trips and sports, are needed to guide IRB decisions and ensure child protection.

Area of Science:

  • Pediatric research ethics
  • Risk assessment in clinical trials
  • Regulatory compliance in human subjects research

Background:

  • United States federal regulations permit institutional review boards (IRBs) to approve pediatric research with minimal risk or a minor increase over minimal risk.
  • Minimal risk is defined by risks ordinarily encountered in daily life or routine examinations.
  • IRB members often rely on intuitive judgment due to a lack of empirical data on pediatric risks.

Purpose of the Study:

  • To provide empirical data on risks encountered by children in daily life and routine activities.
  • To evaluate the consistency of IRB application of the federal minimal risk standard in pediatric research.
  • To inform potential revisions of federal regulations for pediatric research oversight.

Main Methods:

  • Analysis of existing data on mortality risks associated with ordinary activities, specifically car travel.
  • Examination of morbidity risks associated with participation in common children's sports, using basketball as an example.
  • Comparison of empirical risk data with the federal definition of minimal risk for pediatric research.

Main Results:

  • Car trips represent a significant source of ordinary risk for children, with mortality risks ranging from 0.06 to 4 per million depending on age and trip type.
  • Participation in sports like basketball carries higher morbidity risks, with approximately 1900 injuries per million instances, including fractures and permanent disabilities.
  • Findings suggest that IRBs may be overly cautious in applying the minimal risk standard, potentially hindering beneficial pediatric research.

Conclusions:

  • Empirical data on the risks of daily life and sports challenge the current conservative application of the minimal risk standard by IRBs.
  • The federal minimal risk standard may require re-evaluation to ensure it adequately protects children while facilitating necessary research.
  • There is a need for evidence-based guidelines to support IRB decision-making in pediatric research approval.

Related Concept Videos

Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...